The transfer of gentamicin resistance between a coagulase-negative 8. hominis strain and various coagulase-positive 8. aureus strains on human and murine skin in the absence of a selective agent is described. Transfer occurs at higher frequency on skin than in broth. Skin transfer may account for the apparently explosive occurrence of gentamicin resistant staphylococci in hospitals.
INTRODUCTION
Naidoo and Noble (1978a) reported the experimental transmission of gentamicin resistance between two strains of 8taphylococcu8 aureus on human skin and on mouse skin. The strains were isolated from a patient admitted to St John's Hospital for Diseases of the Skin and had been observed to become resistant to gentamicin (apparently as a result of natural plasmid transfer) during topical therapy with an ointment containing gentamicin. The source of the original plasmid was not determined but an '8. ejndermidis' strain with labile gentamicin resistance was isolated from the patient at the same time as the S. aureus strains and was referred to in the description of the ward observations (Naidoo and Noble, 19786) . The transmission of resistance between this coagulase-negative strain and the coagulase-positive strain was briefly described at the Fourth Conference on Staphylococci and Staphylococcal Infection in Warsaw 1979; this report describes the observations in full. Naidoo and Noble (1978a) cultures serially on to gradient plates containing rifampicin until good growth was obtained on media containing 50/tg/ml.
METHODS

Staphylococci. Details of strains are shown in
Media. Oxoid blood agar base was used throughout as described previously (Naidoo & Noble, 1978a) . CY broth (Novick, 1963) was the fluid medium.
Plo8mid transfer. In vivo plasmid transfer was carried out on hairless/obese mice or on the human forearm (Naidoo & Noble, 1978a) .
In vitro transfer was studied by inoculating the strains at high density (c. 10 10 c.f.u./ml) in CY broth and incubating these at 37 °C for 6 h, or by drawing such cultures through Millipore filters (0-45 /tm pore size) the filters being incubated on blood agar base medium at 37 °C for 6 h and the organisms recovered by shaking the filter in broth. Aliquots of broth culture or of filter fluid were then inoculated onto agar containing two antibiotics for recovery of transferants.
The effect of adding CaCl, (001 M) or DNAase (Sigma) (100/tg/ml) to broth culture was also studied. All mouse experiments were made in duplicate and the results pooled. Table 2 shows that it was possible to transfer resistance in mixed culture from the 8. hominis strain to 8. aureus NT strain on human and murine skin and in broth. The reverse transfer was also demonstrated. The protocol for a single experiment is shown in Table 3 . Resistance transfer was also possible from 8. hominis to three 8. aureus phage propagating strains (PS47, PS54, PS83A) in vivo and in vitro and from these strains to a wild type 8. aureus (Si30). Although it was not possible to obtain transfer to 8. aureus PS80 in vivo, in vitro transfer Transfer of gentamicin resistance on skin was achieved and this transferant was also able to transfer resistance to the wild type strain Si30. The addition of CaCl 2 enhanced transfer of resistance from S. hominis to S. aureus PS47 and PS83A by about eight-to tenfold but not to 8. aureus PS54 where it was equal. Since this might indicate phage action, attempts were made to transfer resistance by culture supernatants and by Mitomycin-C induced lysates of 8. hominis but without result. Transfer on filters generally occurred at a lower frequency than in broth suggesting that the stabilizing effect of a solid surface was not the sole skin factor assisting transfer. The effect of DNAase was generally to reduce the apparent rate of transfer by about fivefold.
RESULTS
DISCUSSION
We have shown previously that gentamicin resistance can be transferred between strains of 8. aureus on human and murine skin under conditions resembling those that occur during treatment of skin patients but without the use of antibiotics as a selective agent (Naidoo & Noble, 1078a). We have also described the 186 J. NAIDOO AND W. C. NOBLE Table 3 The support of the Wellcome Trust is gratefully acknowledged. Mrs Mary Rahman is thanked for technical assistance.
